Special note: patients with arrhythmia should not use radiofrequency ablation, that is, it is wrong to cut off the cardiac current conduction pathway (nerve) to stop arrhythmia symptoms. So far, there has not been a case of rehabilitation.
At present, only two mature biomedical engineering products are used to treat arrhythmia in clinic:
1. Arrhythmia cell gene energy therapeutic instrument can completely control or cure arrhythmia patients in the early, middle and early stages of malignant arrhythmia. Efficacy commitment: ensure efficacy, and recall the product without obvious effect (rate) within 20 days.
2. Patients with advanced malignant arrhythmia can wear pacemakers (or defibrillators) in 3A hospitals-that is, they can completely control the arrhythmia and keep the patient's heart normal.
for reference only
Sun Ping